Vanguard Group Inc Amicus Therapeutics, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 29,534,029 shares of FOLD stock, worth $280 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,534,029

Previous 29,407,588 0.43%

Holding current value

$280 Million

Previous $169 Million 38.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$5.84 - $8.57 $738,415 - $1.08 Million	126,441 Added 0.43%	29,534,029 $233 Million
Q2 2025 Aug 11, 2025	BUY	$5.64 - $8.0 $2.01 Million - $2.86 Million	356,967 Added 1.23%	29,407,588 $169 Million
Q1 2025 May 09, 2025	SELL	$8.16 - $9.85 $1.7 Million - $2.05 Million	-208,342 Reduced 0.71%	29,050,621 $237 Million
Q4 2024 Feb 11, 2025	BUY	$9.36 - $12.01 $4.29 Million - $5.5 Million	458,143 Added 1.59%	29,258,963 $276 Million
Q3 2024 Nov 13, 2024	BUY	$9.55 - $12.09 $2.03 Million - $2.57 Million	212,214 Added 0.74%	28,800,820 $308 Million
Q2 2024 Aug 13, 2024	BUY	$9.04 - $11.75 $3.47 Million - $4.52 Million	384,297 Added 1.36%	28,588,606 $284 Million
Q1 2024 May 10, 2024	SELL	$11.43 - $14.24 $3.29 Million - $4.1 Million	-288,177 Reduced 1.01%	28,204,309 $332 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $13.6 Million - $19.8 Million	1,360,613 Added 5.01%	28,492,486 $404 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $1.27 Million - $1.49 Million	107,456 Added 0.4%	27,131,873 $330 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $1.74 Million - $2.16 Million	162,472 Added 0.6%	27,024,417 $339 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $3.53 Million - $4.38 Million	323,574 Added 1.22%	26,861,945 $298 Million
Q4 2022 Feb 10, 2023	BUY	$9.89 - $12.7 $6.6 Million - $8.47 Million	667,309 Added 2.58%	26,538,371 $324 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $1.36 Million - $1.77 Million	138,973 Added 0.54%	25,871,062 $270 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $466,745 - $833,099	74,919 Added 0.29%	25,732,089 $276 Million
Q1 2022 May 13, 2022	BUY	$7.89 - $12.48 $94,569 - $149,585	11,986 Added 0.05%	25,657,170 $243 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $11.4 Million - $14.4 Million	1,156,583 Added 4.72%	25,645,184 $296 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $2.1 Million - $2.85 Million	-240,799 Reduced 0.97%	24,488,601 $234 Million
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $215 Million - $265 Million	24,729,400 New	24,729,400 $238 Million

Others Institutions Holding FOLD

# of Institutions

323

Shares Held

324M

Call Options Held

1.09M

Put Options Held

1.04M

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Amicus Therapeutics, Inc. Transaction History